| Product Code: ETC6174123 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australia`s import trend for the antivirals market experienced a decline, with a growth rate of -2.5% from 2023 to 2024 and a compound annual growth rate (CAGR) of -10.3% for the period 2020-2024. This negative momentum could be attributed to shifts in demand dynamics or changes in market conditions affecting the import landscape.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Antivirals Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Antivirals Market Revenues & Volume, 2022 & 2032F |
3.3 Australia Antivirals Market - Industry Life Cycle |
3.4 Australia Antivirals Market - Porter's Five Forces |
3.5 Australia Antivirals Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Australia Antivirals Market Revenues & Volume Share, By Actions, 2022 & 2032F |
4 Australia Antivirals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Australia |
4.2.2 Rising awareness about the importance of antiviral medications |
4.2.3 Technological advancements in antiviral drug development |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new antiviral drugs |
4.3.2 High cost associated with research and development of antivirals |
5 Australia Antivirals Market Trends |
6 Australia Antivirals Market, By Types |
6.1 Australia Antivirals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Antivirals Market Revenues & Volume, By Type, 2022-2032F |
6.1.3 Australia Antivirals Market Revenues & Volume, By Hepatitis-C antivirals, 2022-2032F |
6.1.4 Australia Antivirals Market Revenues & Volume, By HIV antivirals, 2022-2032F |
6.1.5 Australia Antivirals Market Revenues & Volume, By Herpes antivirals, 2022-2032F |
6.1.6 Australia Antivirals Market Revenues & Volume, By Hepatitis-B antivirals, 2022-2032F |
6.1.7 Australia Antivirals Market Revenues & Volume, By Influenza antivirals, 2022-2032F |
6.1.8 Australia Antivirals Market Revenues & Volume, By Others, 2022-2032F |
6.2 Australia Antivirals Market, By Actions |
6.2.1 Overview and Analysis |
6.2.2 Australia Antivirals Market Revenues & Volume, By DNA polymerase inhibitors, 2022-2032F |
6.2.3 Australia Antivirals Market Revenues & Volume, By NS3 Protease inhibitors, 2022-2032F |
6.2.4 Australia Antivirals Market Revenues & Volume, By Reverse transcriptase inhibitors, 2022-2032F |
6.2.5 Australia Antivirals Market Revenues & Volume, By Others, 2022-2032F |
7 Australia Antivirals Market Import-Export Trade Statistics |
7.1 Australia Antivirals Market Export to Major Countries |
7.2 Australia Antivirals Market Imports from Major Countries |
8 Australia Antivirals Market Key Performance Indicators |
8.1 Number of clinical trials for antiviral medications in Australia |
8.2 Adoption rate of new antiviral drugs in the market |
8.3 Investment in research and development of antiviral drugs |
8.4 Rate of adherence to antiviral treatment regimens |
9 Australia Antivirals Market - Opportunity Assessment |
9.1 Australia Antivirals Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Australia Antivirals Market Opportunity Assessment, By Actions, 2022 & 2032F |
10 Australia Antivirals Market - Competitive Landscape |
10.1 Australia Antivirals Market Revenue Share, By Companies, 2025 |
10.2 Australia Antivirals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here